Insights provides context and perspective about key pharmacy trends and issues

Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q4 2019-Q1 2020 More
Specialty Report
Drug Pipeline
New drugs to treat migraine are approaching approval and could bring relief for many patients, but they portend higher costs. Ongoing monitoring and appropriate utilization strategies can... More
Feature
Drug Pipeline
Biosimilars are a critical tool PBMs can use to help increase market competition and lower costs – we made changes to our template formularies for categories that now have biosimilars... More
Feature
Drug Pipeline
An overview of recently approved therapies, anticipated approvals in the year to come, and strategies to help manage the pipeline More
Feature
Three teenagers eating ice cream on a pier
Drug Pipeline
Peanut allergy is the most common of childhood food allergies — and getting more common. Research presented at the annual meeting of the American College of Allergy, Asthma and Immunology (... More
Feature
Specialty Report PDF icon
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q1-Q2 2019 More
Specialty Report
Group of pills icon
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2018 More
Specialty Report
Two female pharmaceutical scientists working in a lab
Drug Pipeline
When the FDA approves a “supplemental indication” for a drug already on the market — permitting it to be used for new conditions or stages of a disease, or additional patient groups – it... More
Briefing
Male scientist filling liquid drug samples into vials
Drug Pipeline
Scientific developments are altering the pace and focus of specialty drug development, while regulatory changes are shortening approval times. This poses new challenges for payors’ efforts... More
Briefing
Group of pills icon
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2018 More
Specialty Report